drugset / Trial / NCT04771156
Ketorolac in Palatoplasty
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to see if the addition of IV Ketorolac to usual care multi-modal pain therapy compared to usual care will improve oral intake post-operatively
Timeline
- Start
- 2021-09-17
- Primary completion
- 2027-03-01
- Completion
- 2027-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketorolac | Other / unclassified | 0.5 mg/kg | Intravenous |